Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$21.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 9 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 11 business days late.
The 26 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| May 20 | BTAI | BioXcel Therapeutics, Inc. | SSELL◷ | 19,419 | $1.09 | $21.1K | -21.8% | Open the original filing on SEC.gov |
| May 4 | BTAI | BioXcel Therapeutics, Inc. | MEXER◷◆ | 49,758 | — | — | — | Open the original filing on SEC.gov |
| May 4 | BTAI | BioXcel Therapeutics, Inc. | MEXER◷ | 49,758 | — | — | +126.7% | Open the original filing on SEC.gov |
| May 1 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 18,000 | — | — | — | Open the original filing on SEC.gov |
| May 1 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 18,000 | — | — | +84.7% | Open the original filing on SEC.gov |
| Mar 15 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 219 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 219 | — | — | +1.0% | Open the original filing on SEC.gov |
| Mar 14 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 164 | — | — | — | Open the original filing on SEC.gov |
| Mar 14 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 164 | — | — | +0.8% | Open the original filing on SEC.gov |
| Jan 1 | BTAI | BioXcel Therapeutics, Inc. | AGRANT◆ | 199,032 | — | — | — | Open the original filing on SEC.gov |
| Dec 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 219 | — | — | — | Open the original filing on SEC.gov |
| Dec 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 219 | — | — | +1.1% | Open the original filing on SEC.gov |
| Dec 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 164 | — | — | — | Open the original filing on SEC.gov |
| Dec 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 164 | — | — | +0.8% | Open the original filing on SEC.gov |
| Sep 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 219 | — | — | — | Open the original filing on SEC.gov |
| Sep 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 219 | — | — | +1.1% | Open the original filing on SEC.gov |
| Sep 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 163 | — | — | — | Open the original filing on SEC.gov |
| Sep 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 163 | — | — | +0.8% | Open the original filing on SEC.gov |
| Aug 1, 2025 | BTAI | BioXcel Therapeutics, Inc. | AGRANT◆ | 18,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 22, 2025 | BTAI | BioXcel Therapeutics, Inc. | AGRANT | 15,625 | — | — | +348.3% | Open the original filing on SEC.gov |
| Jun 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 219 | — | — | — | Open the original filing on SEC.gov |
| Jun 15, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 219 | — | — | +5.1% | Open the original filing on SEC.gov |
| Jun 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER◆ | 163 | — | — | — | Open the original filing on SEC.gov |
| Jun 14, 2025 | BTAI | BioXcel Therapeutics, Inc. | MEXER | 163 | — | — | +4.0% | Open the original filing on SEC.gov |